Sign In
Buy MBRX
$0.400
-0.620 (-60.78%)
At Close: Jul 31, 2026
Moleculin Announces Trading Halt
11:37pm, Monday, 04'th May 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today annou
SEC takes action against three more companies over COVID-19 claims
07:51pm, Monday, 04'th May 2020
The Securities and Exchange Commission temporarily halted trading in three more stocks on Monday because of questions regarding the accuracy of information...
Moleculin to Speak on COVID-19 Panel at Maxim Group's Infectious Disease Virtual Conference
11:30am, Wednesday, 29'th Apr 2020
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today annou
The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt
11:53am, Thursday, 23'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Johns
EXEL, TNK among premarket gainers
01:08pm, Monday, 20'th Apr 2020
Avalon GloboCare (NASDAQ:AVCO) +44% on advancing immunotherapeutic program towards combatting cytokine storm associated with COVID-19 lung damage and mortality.Safe-T Group Ltd (NASDAQ:SFET) +41% on
INO, BBBY among premarket gainers
01:19pm, Thursday, 16'th Apr 2020
Edison Nation (NASDAQ:EDNT) +169% on over $10M order.Soligenix (NASDAQ:SNGX) +91% on deal for COVID-19 vaccine adjuvant.Atossa Therapeutics (NASDAQ:ATOS) +82% on launching COVID-19 HOPE drug devel
The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant
12:09pm, Thursday, 16'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 15.) * Bio-Rad Laboratories, Inc. Class B Common Stock
Analysts Are Bullish on These Healthcare Stocks: Moleculin Biotech (MBRX), Axonics Modulation Technologies (AXNX)
07:07pm, Wednesday, 15'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Moleculin Biotech (MBRX) and Axonics Modulation
Analysts Are Bullish on These Healthcare Stocks: Moleculin Biotech (MBRX), Axonics Modulation Technologies (AXNX)
07:07pm, Wednesday, 15'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Moleculin Biotech (
MBRX
–
Research Report
) and Axonics Modulation Technologies (
AXNX
–
Research
ROKU, CCL among premarket gainers today
01:20pm, Tuesday, 14'th Apr 2020
Sonnet BioTherapeutics Holdings (NASDAQ:SONN) +100%.MEI Pharma (NASDAQ:MEIP) +71% on license deal for blood cancer candidate.NantKwest (NASDAQ:NK) +39% being with ImmunityBio on active discussion
Moleculin Biotech (NASDAQ:MBRX) Receives New Coverage from Analysts at Maxim Group
07:38am, Friday, 10'th Apr 2020
Research analysts at Maxim Group began coverage on shares of Moleculin Biotech (NASDAQ:MBRX) in a research report issued to clients and investors on Thursday, TipRanks reports. The brokerage set a “
Moleculin Biotech (MBRX) Gets a Buy Rating from Maxim Group
03:04pm, Thursday, 09'th Apr 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Moleculin Biotech (MBRX), with a price target of $3.00. The company's
Moleculin Biotech (MBRX) Gets a Buy Rating from Maxim Group
03:04pm, Thursday, 09'th Apr 2020
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to Moleculin Biotech (MBRX – Research
86 Biggest Movers From Yesterday
09:43am, Thursday, 09'th Apr 2020
Gainers
Moleculin Biotech Inc (NASDAQ: MBRX) shares jumped 125.7% to close at $1.27 on Wednesday after it said that independent research found 2-deoxy-D-glucose (2-DG)to reduce...
Mid-Afternoon Market Update: Dow Surges Over 600 Points; Moleculin Biotech Shares Climb
06:36pm, Wednesday, 08'th Apr 2020
Toward the end of trading Wednesday, the Dow traded up 2.73% to 23,272.17 while the NASDAQ rose 2.04% to 8,048.18. The S&P also rose, gaining 2.76% to 2,732.88.
The U.S. is...
